Structure of Paroxetine Hydrochloride CAS 110429-35-1Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

110429-35-1

Name

Parox­e­tine Hydrochlo­ride

Syn­onyms

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochlo­ride hydrate (2:2:1) [ACD/IUPAC Name] (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)méthyl]-4-(4-fluorophényl)pipéridine, chlorhy­drate, hydrate (2:2:1) [French] [ACD/IUPAC Name] (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorphenyl)piperidinhydrochloridhydrat (2:2:1) [Ger­man] [ACD/IUPAC Name] 110429-35-1 [RN] parox­e­tine hydrochlo­ride ;(-)trans-3-[(1,3-benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl) parox­e­tine hydrochlo­ride Parox­e­tine hydrochlo­ride hydrate Piperi­dine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-, hydrochlo­ride, hydrate (2:2:1) [ACD/​Index Name] (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrate dihy­drochlo­ride (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrate;dihydrochloride Dihy­drochlo­ride hydrate MFCD00797405 [MDL num­ber] MFCD09028022 [MDL num­ber] Parox­e­tine HCl Parox­e­tine Hydrochlo­ride Parox­e­tine Hydrochlo­ride Hemi­hy­drate 1.0 mg/​ml in Methanol (as anhy­drous free base) Pax­il [Trade name] UNII :X2ELS050D8 UNII-X2EL­S050D8

Mol­e­c­u­lar Structure

Structure of Paroxetine Hydrochloride CAS 110429-35-1

Struc­ture of Parox­e­tine Hydrochlo­ride CAS 110429-35-1

SMILES

c1cc(ccc1[C@@H]2CCNC[C@H]2COc3ccc4c(c3)OCO4)F.c1cc(ccc1[C@@H]2CCNC[C@H]2COc3ccc4c(c3)OCO4)F.O.Cl.Cl

Std­InChI

InChI=1S/2C19H20FNO3.2ClH.H2O/c2*20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;;;/h2*1-6,9,14,17,21H,7-8,10-12H2;2*1H ;1H2/t2*14-,17-;;;/m00…/s1

Std­InChIKey

MQZOAT­SIFWSKKT-OASX­IEI­ISA-N

Mol­e­c­u­lar Formula

C38H44Cl2F2N2O7

Mol­e­c­u­lar Weight

749.66

MDL Number

MFCD03658863

Safe­ty Data

Sym­bol

Sig­nal Word

Warn­ing

Haz­ard Statements

H302-H411

Pre­cau­tion­ary Statements

P301 + P312 + P330

Per­son­al Pro­tec­tive Equipment

dust mask type N95 (US), Eye­shields, Gloves

RIDADR

UN 3077 9 / PGI­II

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Parox­e­tine Hydrochlo­ride CAS 110429-35-1

Stan­dard

EP, USP

GMP

CFDA

Basic Patent Situation

US expiry date20070629
EU expiry date20061014
JP expiry date20111024

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the Anti-depres­sant

Links

This prod­uct is devel­oped by our R&D com­pa­ny Wat­son­noke Sci­en­tif­ic Ltd(http://​www​.wat​son​noke​.com/), and here is the cor­re­spond­ing linkhttp://​www​.wat​son​noke​.com/​p​a​r​o​x​e​t​i​n​e​-​h​y​d​r​o​c​h​l​o​r​i​d​e​-​c​a​s​-​1​1​0​4​2​9​-​3​5​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the plane.